Fig. 3From: Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005–2018Participant flow showing number analyzed and per protocol treatment outcomes. ASAQ Artesunate-amodiaquine, AL Artemether-lumefantrine; LFU Loss to follow-up, WTH Withdrawn, ACPR Adequate clinical and parasitological response, ETF Early treatment failure; LCF Late clinical failure, LPF Late parasitological failureBack to article page